TrialInternational journal of hematology2015
Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim.
Douglas B Cines et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
44 papers cite it
this paperpooled ittrialcites it